glp-1 gastric intestinal obstruction class action in west virginia Glucagon-like peptide-1 drugs, gastrointestinal... : Current Opinion in Critical Care glp-1 gastric intestinal obstruction class

In 2019, elevated BMI was responsible for approximately 5 million deaths due to noncommunicable diseases (NCDs) worldwide [1]

Once the first GLP-1 verdicts are returned, the MDL settlement framework typically follows within 1224 months

This doesnt necessarily mean GLP-1s are bad, but there is a chance that future safety concerns will surface

So that when and if they do choose to come off the drug, theres less of a rebound. GLP-1 drugs have helped millions manage their weight and glucose in ways that once were impossible

In addition to the drugs potential direct implications in treating those conditions, employers also are considering the possible longer-term health effects of treating obesity, such as reduced risk of chronic conditions which can lower health costs in the future given the prevalence of obesity and the cost of not treating it, Schuman said